| Drug Name: | Levallorphan (152-02-3) |
|---|---|
| PubChem ID: | 5359371 |
| SMILES: | C=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O |
| InchiKey: | OZYUPQUCAUTOBP-QXAKKESOSA-N |
| Therapeutic Category: | Central Nervous System Agents, Narcotic Antagonists, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 283.415 |
| LogP | : | 3.6366 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 23.47 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Miosis | MetaADEDB |
| Muscle Rigidity | MetaADEDB |
| Substance Withdrawal Syndrome | MetaADEDB |
| Weight Loss | MetaADEDB |